.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Trospium chloride - Generic Drug Details

« Back to Dashboard
Trospium chloride is the generic ingredient in three branded drugs marketed by Allergan, Apotex, Upsher-smith Labs, Heritage Pharms Inc, Paddock Llc, Glenmark Generics, Invagen Pharms, and Actavis Labs Fl Inc, and is included in ten NDAs. There are five patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

This ingredient has thirteen patent family members in nine countries.

There are sixteen drug master file entries for trospium chloride. Nine suppliers are listed for this compound.

Summary for Generic Name: trospium chloride

Tradenames:3
Patents:5
Applicants:8
NDAs:10
Drug Master File Entries: see list16
Suppliers / Packaging: see list9
Therapeutic Class:Genitourinary Agents
Drug Prices:see low prices

Pharmacology for Ingredient: trospium chloride

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Heritage Pharms Inc
TROSPIUM CHLORIDE
trospium chloride
TABLET;ORAL204945-001Aug 30, 2016RXNo► subscribe► subscribe
Glenmark Generics
TROSPIUM CHLORIDE
trospium chloride
TABLET;ORAL091575-001Aug 13, 2010RXYes► subscribe► subscribe
Apotex
TROSPIUM CHLORIDE
trospium chloride
TABLET;ORAL091513-001Dec 6, 2011RXNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: trospium chloride

Country Document Number Estimated Expiration
European Patent Office2210605► subscribe
Germany602004030931► subscribe
Australia2004289223► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc